Comparing the Tirzepatide Price at Major Pharmacies

What Drives the Cost of Tirzepatide

Tirzepatide, sold under the brand name Mounjaro for type 2 diabetes and Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist manufactured by Eli Lilly. Because it targets two incretin pathways simultaneously, it represents a newer class of therapy compared to earlier GLP-1 drugs, and that novelty is reflected in its retail pricing. The tirzepatide price is influenced by the dose strength you are prescribed, whether you use insurance, and which pharmacy fills your prescription. Doses range from 2.5 mg up to 15 mg per weekly injection, and higher doses carry higher list prices at virtually every major retailer.

Retail Prices at Major Chain Pharmacies

Without insurance or a manufacturer coupon, the cash price for a four-week supply of Mounjaro or Zepbound typically falls between $1,000 and $1,300 depending on the dose. Below is a general comparison based on publicly listed prices and pharmacy benefit data as of early 2026. Actual prices fluctuate and should be verified directly with each pharmacy before filling.

• CVS Pharmacy: List price for a monthly supply of Zepbound 5 mg runs approximately $1,059. The CVS CarePass program offers modest discounts but does not dramatically reduce the out-of-pocket cost without a manufacturer coupon.
• Walgreens: Cash prices align closely with CVS, typically landing between $1,050 and $1,100 for starter doses. Walgreens myWalgreens rewards provide minimal relief on specialty biologics.
• Rite Aid: Where still operational, Rite Aid prices trend slightly higher than the two largest chains, often exceeding $1,100 for the same dose.
• Costco Pharmacy: Costco consistently offers some of the lowest cash prices among major retailers, with monthly supplies frequently priced between $900 and $980 for lower doses. No membership is required to use a Costco pharmacy.
• Walmart Health and Wellness: Walmart's cash price for tirzepatide sits near the national average of roughly $1,050 to $1,080. The Walmart Plus membership does not currently include a meaningful tirzepatide discount.
• Mark Cuban's Cost Plus Drugs: Not a traditional pharmacy chain, but Cost Plus has listed compounded or generic alternatives at dramatically lower prices. It does not currently carry the branded Eli Lilly products.

Insurance Coverage and Manufacturer Savings Cards

Commercial insurance coverage for tirzepatide varies significantly by plan and indication. Mounjaro prescribed for type 2 diabetes is more frequently covered than Zepbound prescribed for obesity, reflecting longstanding disparities in how insurers treat metabolic disease. Patients with qualifying commercial insurance can use the Eli Lilly Savings Card, which has historically reduced the tirzepatide price to as low as $25 for a four-week supply for eligible patients. This savings card is not valid for Medicare, Medicaid, or other federal programs, and income-based eligibility restrictions apply. Patients without insurance should ask their prescriber about the Lilly Insulin Value Program or the LillyForYou patient assistance program if cost is a barrier.

Mail-Order and Specialty Pharmacy Options

Many insurance plans require or incentivize the use of a preferred mail-order pharmacy for maintenance medications, and tirzepatide qualifies as a maintenance therapy once a stable dose is reached. Express Scripts, OptumRx, and CVS Caremark each negotiate different net prices with Eli Lilly through rebate agreements, which can make the patient copay lower through mail-order than at retail even for the same plan. Specialty pharmacies such as Accredo or Diplomat sometimes carry tirzepatide when local retail pharmacies face supply shortages, though their cash prices are generally not lower than chain retailers.

Compounded Tirzepatide and the Regulatory Landscape

During periods when the FDA listed tirzepatide as in shortage, compounding pharmacies were legally permitted to produce copies of the drug. The FDA removed tirzepatide from its shortage list in late 2024, triggering a phase-out period for most compounders. As of 2025 and into 2026, FDA enforcement actions have further restricted which facilities may continue compounding. Compounded versions were often priced between $200 and $600 per month, making them attractive on cost grounds, but they carry different safety profiles and are not bioequivalent to the branded product by FDA standards. Patients comparing the tirzepatide price across all options should weigh the regulatory status of any compounding source carefully before switching from a branded product.

How to Get the Lowest Price Available to You

The most reliable strategy for minimizing out-of-pocket cost is to combine insurance coverage with the Eli Lilly Savings Card where eligible. For uninsured patients, Costco Pharmacy and GoodRx coupons redeemable at multiple chains currently offer the most competitive cash pricing. GoodRx and similar discount platforms negotiate group rates that can reduce the cost at Kroger, Publix, and regional grocery pharmacies to levels competitive with the largest chains. Telehealth platforms that prescribe tirzepatide sometimes bundle the prescription with a partner pharmacy at a negotiated rate, which can simplify the process but may not always represent the lowest available price in your zip code. Calling ahead to verify current stock and price before traveling to a pharmacy remains practical advice given ongoing supply fluctuations in this drug class.